These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31435939)

  • 1. Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer.
    Metcalfe KA; Retrouvey H; Kerrebijn I; Butler K; O'Neill AC; Cil T; Zhong T; Hofer SOP; McCready DR
    Cancer; 2019 Nov; 125(22):3966-3973. PubMed ID: 31435939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
    Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result.
    Metcalfe KA; Eisen A; Poll A; Candib A; McCready D; Cil T; Wright F; Demsky R; Mancuso T; Sun P; Narod SA
    Ann Surg Oncol; 2021 Sep; 28(9):4967-4973. PubMed ID: 33761021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
    Rosenberg SM; Sepucha K; Ruddy KJ; Tamimi RM; Gelber S; Meyer ME; Schapira L; Come SE; Borges VF; Golshan M; Winer EP; Partridge AH
    Ann Surg Oncol; 2015 Nov; 22(12):3809-15. PubMed ID: 25930247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
    J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
    Tynan M; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill SC; Jandorf L; Kelly SP; Heinzmann J; Kelleher S; Poggi E; Schwartz MD
    Breast Cancer Res Treat; 2020 Feb; 180(1):177-185. PubMed ID: 31894446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
    Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
    Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer.
    Parker PA; Peterson SK; Shen Y; Bedrosian I; Black DM; Thompson AM; Nelson JC; DeSnyder SM; Cook RL; Hunt KK; Volk RJ; Cantor SB; Dong W; Brewster AM
    J Clin Oncol; 2018 Sep; 36(25):2630-2638. PubMed ID: 30044695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.
    Graves KD; Peshkin BN; Halbert CH; DeMarco TA; Isaacs C; Schwartz MD
    Breast Cancer Res Treat; 2007 Sep; 104(3):321-9. PubMed ID: 17066320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Study of Surgical Decision-making Processes for Contralateral Prophylactic Mastectomy in Women With Breast Cancer.
    Parker PA; Peterson SK; Bedrosian I; Crosby MA; Shen Y; Black DM; Babiera G; Kuerer HM; Ying J; Dong W; Cantor SB; Brewster AM
    Ann Surg; 2016 Jan; 263(1):178-83. PubMed ID: 25822675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Satisfaction and Body Image After Contralateral Prophylactic Mastectomy.
    Anderson C; Islam JY; Elizabeth Hodgson M; Sabatino SA; Rodriguez JL; Lee CN; Sandler DP; Nichols HB
    Ann Surg Oncol; 2017 Jun; 24(6):1499-1506. PubMed ID: 28058563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
    Jagsi R; Hawley ST; Griffith KA; Janz NK; Kurian AW; Ward KC; Hamilton AS; Morrow M; Katz SJ
    JAMA Surg; 2017 Mar; 152(3):274-282. PubMed ID: 28002555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.
    Rosenberg SM; Tracy MS; Meyer ME; Sepucha K; Gelber S; Hirshfield-Bartek J; Troyan S; Morrow M; Schapira L; Come SE; Winer EP; Partridge AH
    Ann Intern Med; 2013 Sep; 159(6):373-81. PubMed ID: 24042365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contralateral prophylactic mastectomy in young women with breast cancer: a population-based analysis of predictive factors and clinical impact.
    Bouchard-Fortier A; Baxter NN; Sutradhar R; Fernandes K; Camacho X; Graham P; Quan ML
    Curr Oncol; 2018 Dec; 25(6):e562-e568. PubMed ID: 30607124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
    Elsayegh N; Webster RD; Gutierrez Barrera AM; Lin H; Kuerer HM; Litton JK; Bedrosian I; Arun BK
    Cancer Med; 2018 Jun; 7(6):2718-2726. PubMed ID: 29733510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.
    Elsayegh N; Kuerer HM; Lin H; Gutierrez Barrera AM; Jackson M; Muse KI; Litton JK; Albarracin C; Afrough A; Hortobagyi GN; Arun BK
    Ann Surg Oncol; 2014 Oct; 21(11):3466-72. PubMed ID: 24796968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
    Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
    Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic mastectomy for the prevention of breast cancer.
    Lostumbo L; Carbine N; Wallace J; Ezzo J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.